HUP9802647A3 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors - Google Patents

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Info

Publication number
HUP9802647A3
HUP9802647A3 HU9802647A HUP9802647A HUP9802647A3 HU P9802647 A3 HUP9802647 A3 HU P9802647A3 HU 9802647 A HU9802647 A HU 9802647A HU P9802647 A HUP9802647 A HU P9802647A HU P9802647 A3 HUP9802647 A3 HU P9802647A3
Authority
HU
Hungary
Prior art keywords
bis
amino acid
protease inhibitors
retroviral protease
hydroxyethylamino sulfonamide
Prior art date
Application number
HU9802647A
Other languages
English (en)
Original Assignee
G D Searle & Co Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G D Searle & Co Chicago filed Critical G D Searle & Co Chicago
Publication of HUP9802647A2 publication Critical patent/HUP9802647A2/hu
Publication of HUP9802647A3 publication Critical patent/HUP9802647A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
HU9802647A 1995-03-10 1996-03-07 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors HUP9802647A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40245095A 1995-03-10 1995-03-10
US08/479,071 US6150556A (en) 1995-03-10 1995-06-07 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Publications (2)

Publication Number Publication Date
HUP9802647A2 HUP9802647A2 (hu) 1999-02-01
HUP9802647A3 true HUP9802647A3 (en) 2000-10-30

Family

ID=27017890

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802647A HUP9802647A3 (en) 1995-03-10 1996-03-07 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Country Status (23)

Country Link
US (2) US6150556A (hu)
EP (2) EP1076062A1 (hu)
JP (1) JPH11501921A (hu)
KR (1) KR100428499B1 (hu)
CN (1) CN1178954C (hu)
AT (1) ATE304550T1 (hu)
AU (1) AU704360B2 (hu)
BR (1) BR9607543A (hu)
CA (1) CA2215025A1 (hu)
CZ (1) CZ294966B6 (hu)
DE (1) DE69635183T2 (hu)
DK (1) DK0813543T3 (hu)
EA (1) EA000578B1 (hu)
EE (1) EE04376B1 (hu)
ES (1) ES2249779T3 (hu)
HU (1) HUP9802647A3 (hu)
MX (1) MX9706913A (hu)
NO (3) NO325230B1 (hu)
NZ (1) NZ305544A (hu)
PL (2) PL185543B1 (hu)
SK (2) SK285930B6 (hu)
UA (1) UA55384C2 (hu)
WO (1) WO1996028464A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122000A1 (en) 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US7339078B2 (en) * 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1188766A1 (en) * 1995-03-10 2002-03-20 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO2000002862A1 (en) 1998-07-08 2000-01-20 G.D. Searle & Co. Retroviral protease inhibitors
HUP0105235A3 (en) * 1999-01-13 2002-08-28 Pont Pharmaceuticals Company W Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors, pharmaceutical compositions comprising thereof and their use
AR031520A1 (es) * 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
US6391919B1 (en) 2000-01-12 2002-05-21 Bristol-Myers Squibb Pharma Company Bis-amino acid sulfonamides containing substituted benzyl amines HIV protease inhibitors
US20020022742A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Salt forms of an HIV protease inhibitor
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
US20020022659A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Crystalline and salt forms of an HIV protease inhibitor
ES2275866T3 (es) 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
AP1544A (en) * 2001-04-09 2006-01-12 Tibotec Pharm Ltd Broadspectrum 2- (substituted-amino) -benzoxazole sulfonamide HIV protease inhibitors.
EA009590B1 (ru) * 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
US6562848B1 (en) 2001-09-18 2003-05-13 Bristol-Myers Squibb Company Bis-amino acid sulfonamides as HIV protease inhibitors
JP4578101B2 (ja) 2001-12-21 2010-11-10 テイボテク・フアーマシユーチカルズ・リミテツド 幅広いスペクトルのhivプロテアーゼ阻害剤である複素環置換フェニル含有スルホンアミド
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
ATE371652T1 (de) * 2002-05-17 2007-09-15 Tibotec Pharm Ltd Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
JP4681296B2 (ja) 2002-08-14 2011-05-11 テイボテク・フアーマシユーチカルズ・リミテツド スペクトルの広い置換オキシインドールスルホンアミドhivプロテアーゼ阻害剤
US20060128634A1 (en) * 2002-11-14 2006-06-15 Carini David J Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
US6943170B2 (en) * 2002-11-14 2005-09-13 Bristol-Myers Squibb Company N-cycloalkylglycines as HIV protease inhibitors
EP1651192A1 (en) * 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
US8193227B2 (en) 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
DK1725566T3 (da) 2003-12-23 2009-10-05 Tibotec Pharm Ltd Fremgangsmåde til fremstilling af (3R,3AS, 6AR)-hexahydrofuro [2,3.B] furan-3-yl (1S,2R)-3-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamat
US7772411B2 (en) 2003-12-23 2010-08-10 Tibotec Pharmaceuticals Ltd. Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
KR101192127B1 (ko) 2006-11-03 2012-10-17 쉐링-프라우 리미티드 개 라임병 백신
BRPI0819883A2 (pt) 2007-11-28 2017-05-23 Sequoia Pharmaceuticals Inc composições e métodos para inibir citocromo p450 2d6
WO2013009923A1 (en) * 2011-07-13 2013-01-17 Creighton University Methods of promoting neuron growth
US20150113867A1 (en) 2013-10-24 2015-04-30 Basf Se Use of an alkoxylated polytetrahydrofuran to reduce fuel consumption
CN104478830B (zh) * 2014-12-31 2016-06-22 中国医学科学院医药生物技术研究所 一组叔胺类拟肽衍生物及其在抑制hiv-1蛋白酶中的应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
DE3377497D1 (en) * 1982-09-15 1988-09-01 Haessle Ab Enzyme inhibitors
US4595407A (en) * 1982-11-01 1986-06-17 E. I. Du Pont De Nemours And Company Triazinyl-amino-carbonyl-1,3-benzohetero- or -1,4-benzohetero-sulfonamides
EP0114993B1 (en) * 1982-12-27 1990-05-16 Merck & Co. Inc. Renin inhibitory tripeptides
US4668770A (en) * 1982-12-27 1987-05-26 Merck & Co., Inc. Renin inhibitory tripeptides
AU573735B2 (en) * 1983-02-07 1988-06-23 Aktiebolaget Hassle Peptide analogue enzyme inhibitors
JPS59227851A (ja) * 1983-06-09 1984-12-21 Sankyo Co Ltd レニン阻害作用を有するペプチド類
US4514391A (en) * 1983-07-21 1985-04-30 E. R. Squibb & Sons, Inc. Hydroxy substituted peptide compounds
US4477441A (en) * 1983-09-14 1984-10-16 Merck & Co., Inc. Renin inhibitors containing a C-terminal disulfide cycle
US4645759A (en) * 1984-06-22 1987-02-24 Abbott Laboratories Renin inhibiting compounds
US4616088A (en) * 1984-10-29 1986-10-07 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitor
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
US4668769A (en) * 1985-08-02 1987-05-26 Hoover Dennis J Oxa- and azahomocyclostatine polypeptides
CA1282549C (en) * 1985-11-12 1991-04-02 Eric M. Gordon Aminocarbonyl renin inhibitors
US4757050A (en) * 1985-12-23 1988-07-12 E. R. Squibb Sons, Inc. Ureido renin inhibitors
CA1297631C (en) * 1985-12-23 1992-03-17 Sesha I. Natarajan Ureido renin inhibitors
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
DE3635907A1 (de) * 1986-10-22 1988-04-28 Merck Patent Gmbh Hydroxy-aminosaeurederivate
CH676988A5 (hu) * 1987-01-21 1991-03-28 Sandoz Ag
USH725H (en) * 1987-02-26 1990-01-02 E. R. Squibb & Sons, Inc. Ureido amino and imino acids, compositions and methods for use
GB8707412D0 (en) * 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
DE3830825A1 (de) * 1987-09-15 1989-03-23 Sandoz Ag Hydrophile reninhemmer, ihre herstellung und verwendung
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
US4977277A (en) * 1988-05-09 1990-12-11 Abbott Laboratories Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof
IL90218A0 (en) * 1988-05-13 1989-12-15 Abbott Lab Retroviral protease inhibitors
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
IL91307A0 (en) * 1988-08-24 1990-03-19 Merck & Co Inc Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them
CA2012306A1 (en) * 1989-03-28 1990-09-28 Werner Neidhart Amino acid derivatives
JP2701932B2 (ja) * 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
DE3912829A1 (de) * 1989-04-19 1990-10-25 Bayer Ag Verwendung von renininhibitorischen peptiden als mittel gegen retroviren
TW225540B (hu) * 1990-06-28 1994-06-21 Shionogi & Co
DE69118907T2 (de) * 1990-11-19 1996-11-14 Monsanto Co Retrovirale proteaseinhibitoren
WO1993013066A1 (en) * 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
US5843946A (en) * 1992-08-25 1998-12-01 G.D. Searle & Co. α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
JP4091654B2 (ja) * 1992-08-25 2008-05-28 ジー.ディー.サール、リミテッド、ライアビリティ、カンパニー レトロウイルスプロテアーゼ阻害剤として有用なスルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DE69319351T2 (de) * 1992-10-30 1998-11-19 Searle & Co Hydroxyethylaminosulfamidsäure-derivate verwendbar als inhibitoren retroviraler proteasen
ES2127938T3 (es) * 1993-08-24 1999-05-01 Searle & Co Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій

Also Published As

Publication number Publication date
US6150556A (en) 2000-11-21
EA199700220A1 (ru) 1998-02-26
NZ305544A (en) 1999-04-29
NO974149L (no) 1997-11-05
SK285958B6 (sk) 2007-12-06
AU704360B2 (en) 1999-04-22
CN1196732A (zh) 1998-10-21
EA000578B1 (ru) 1999-12-29
KR100428499B1 (ko) 2004-11-16
MX9706913A (es) 1997-11-29
EP1076062A1 (en) 2001-02-14
NO20075806L (no) 1997-11-05
EE04376B1 (et) 2004-10-15
WO1996028464A1 (en) 1996-09-19
UA55384C2 (uk) 2003-04-15
PL185543B1 (pl) 2003-05-30
NO974149D0 (no) 1997-09-09
US6316496B1 (en) 2001-11-13
JPH11501921A (ja) 1999-02-16
EE9700200A (et) 1998-02-16
HUP9802647A2 (hu) 1999-02-01
DE69635183D1 (de) 2005-10-20
CN1178954C (zh) 2004-12-08
PL322163A1 (en) 1998-01-19
DK0813543T3 (da) 2006-01-16
AU5356196A (en) 1996-10-02
NO325230B1 (no) 2008-03-03
KR19980702908A (ko) 1998-09-05
SK285930B6 (sk) 2007-11-02
PL185108B1 (pl) 2003-02-28
NO20075810L (no) 1997-11-05
BR9607543A (pt) 1997-12-23
EP0813543A1 (en) 1997-12-29
DE69635183T2 (de) 2006-06-29
CZ282597A3 (cs) 1998-02-18
ATE304550T1 (de) 2005-09-15
CA2215025A1 (en) 1996-09-19
ES2249779T3 (es) 2006-04-01
EP0813543B1 (en) 2005-09-14
CZ294966B6 (cs) 2005-04-13
SK122297A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
HUP9802647A3 (en) Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
HUP9801562A3 (en) Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
AU7722296A (en) Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
GR3030719T3 (en) Sulfonamide inhibitors of hiv-aspartyl protease.
HUP9800518A3 (en) Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
IL128080A0 (en) Thiol sulfonamide metalloprotease inhibitors
CY2317B1 (en) Thf-containing sulfonamide inhibitors of aspartyl protease.
PL326508A1 (en) Protease inhibitors
PL336625A1 (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
ZA915269B (en) Retroviral protease inhibitors
HUP0002247A3 (en) Protease inhibitors
IL132630A0 (en) Protease inhibitors
ZA939432B (en) Retroviral protease inhibitors
ZA983522B (en) Protease inhibitors
HUP9802764A3 (en) Guanidino protease inhibitors
HU9602748D0 (en) Novel sulfonamide
HK1047440A1 (zh) 雙氨基酸羥乙基氨基氨磺酰逆轉錄病毒蛋白酶阻聚劑
EP1015438A4 (en) PROTEASE INHIBITORS
EP0628035A4 (en) RETROVIRAL PROTEASE INHIBITORS.
EP0566237A3 (en) Retroviral protease inhibitors.
EP0975612A4 (en) PROTEASE INHIBITORS
SI0813542T1 (en) Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
AU4862799A (en) Retroviral protease inhibitors
AU4688893A (en) Sulfonamide tetrazole acat inhibitors

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees